PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,530,898 | +9.0% | 1,126,214 | +13.9% | 0.00% | 0.0% |
| Q2 2023 | $17,911,118 | +56.5% | 988,472 | +129.8% | 0.00% | +100.0% |
| Q1 2023 | $11,443,834 | +169262.6% | 430,219 | +23.1% | 0.00% | 0.0% |
| Q4 2022 | $6,757 | -99.9% | 349,608 | +6.6% | 0.00% | 0.0% |
| Q3 2022 | $6,849,000 | +286.9% | 327,868 | +48.4% | 0.00% | – |
| Q2 2022 | $1,770,000 | -37.8% | 220,983 | -45.5% | 0.00% | – |
| Q1 2022 | $2,844,000 | -47.3% | 405,815 | +1.5% | 0.00% | -100.0% |
| Q4 2021 | $5,395,000 | -0.3% | 399,694 | +24.7% | 0.00% | 0.0% |
| Q3 2021 | $5,409,000 | -34.1% | 320,454 | +13.7% | 0.00% | 0.0% |
| Q2 2021 | $8,207,000 | -26.0% | 281,856 | -0.1% | 0.00% | -50.0% |
| Q1 2021 | $11,096,000 | +228.3% | 282,132 | +89.6% | 0.00% | +100.0% |
| Q4 2020 | $3,380,000 | +10.5% | 148,801 | +10.2% | 0.00% | 0.0% |
| Q3 2020 | $3,059,000 | +409.8% | 135,072 | +630.4% | 0.00% | – |
| Q2 2020 | $600,000 | – | 18,493 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |